| Mrs Julie Anna Mays, MS,CCC-SLP | |
|
511 E Lee Ave, Sapulpa, OK 74066-4308 | |
| (918) 224-3400 | |
| (918) 227-8348 |
| Full Name | Mrs Julie Anna Mays |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 511 E Lee Ave, Sapulpa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558705939 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 3952 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Julie Anna Mays, MS,CCC-SLP 511 E Lee Ave, Sapulpa, OK 74066-4308 Ph: (918) 224-3400 | Mrs Julie Anna Mays, MS,CCC-SLP 511 E Lee Ave, Sapulpa, OK 74066-4308 Ph: (918) 224-3400 |
News Archive
Direct-to-consumer advertising for drugs to treat testosterone deficiency - or "low T" - increases prescriptions to men for hormone-replacement therapies but may not improve their health, UC Davis physician Richard Kravitz said in an editorial published in the March 21 issue of the Journal of the American Medical Association.
Researchers funded by the National Institute of Mental Health (NIMH), have found that requests from patients for medications have a "profound effect" on physicians prescribing for major depression and adjustment disorder. These findings indicate that direct-to-consumer (DTC) marketing of prescription medications for depression may exert significant influence on treatment decisions.
University of Minnesota researchers have discovered and received a patent for a naturally occurring lantibiotic - a peptide produced by a harmless bacteria - that could be added to food to kill harmful bacteria like salmonella, E. coli and listeria.
Polynoma LLC, a U.S. oncology-focused biopharmaceutical company within Hong Kong-based CK Life Sciences Int'l., today announced the start of a Phase III clinical trial program for POL 103A, the Company's novel melanoma vaccine. Polynoma's global, multi-center, double-blind, placebo-controlled Melanoma Antigen Vaccine Immunotherapy Study (MAVIS) is designed to enroll a total of 1059 patients with resected Stage IIb, IIc or III melanoma.
Logically, it would seem that more follow-up testing of cancer patients must be better than less - but this is not the case for patients who undergo surgery for colorectal cancer.
› Verified 1 days ago
Ms. Anna Lee Lamers, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9 N Water St Ste 107, Sapulpa, OK 74066 Phone: 918-224-5400 | |
Mrs. Kristina Parsons Beck, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1808 S Hickory St, Sapulpa, OK 74066 Phone: 918-224-5531 Fax: 918-224-1739 | |
Mrs. Casey Nelson, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1231 E Dewey Ave, Sapulpa, OK 74066 Phone: 918-227-6800 | |
Kristin Carter, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 W Taft Ave, Sapulpa, OK 74066 Phone: 918-615-6492 | |
Jessica Macdonald, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9171 Freedom Rd, Sapulpa, OK 74066 Phone: 918-227-7838 | |
Tara Lynn Simpson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 511 E Lee Ave, Sapulpa, OK 74066 Phone: 918-224-3400 | |
Mrs. Genevieve Misener Veitch, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 511 E Lee Ave, Sapulpa, OK 74066 Phone: 918-224-3400 |